Organisation paid for research Program year 2025 Source: CMS Open Payments

Advanced Investigative Medicine

Neither a doctor nor a teaching hospital

Research payments

$834,751

78 payments

Through program year 2025, Advanced Investigative Medicine is reported as receiving $834,751 in research payments, across 78 payments.

By program year

5 rows
Year Kind Amount Payments
2025 Research $16,900 1
2024 Research $579,447 51
2023 Research $230,792 15
2022 Research $6,446 3
2021 Research $1,165 8

Breakdown

Who paid Research payments · program years 2021–2025
  1. Roche Molecular Systems, Inc. $662,360 58 payments
  2. Roche Diagnostics Operations, Inc. $171,226 12 payments
  3. Pfizer Inc. $1,165 8 payments
Studies the money was for Research payments · program years 2021–2025
  1. Rd006493 $304,243 23 payments
  2. Rd006890 $288,866 27 payments
  3. Rd006484 $171,226 12 payments
  4. Rd006494 $69,251 8 payments
  5. A Phase 3 Randomized Doubleblind Trial to Evaluate the Safety and Immunogenicity of A 20Valent Pneumococcal Conjugate Vaccine in Healthy Infants $1,165 8 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record